Research & Development
13 September 2019 - - Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) has launched Fosaprepitant for Injection, the therapeutic generic equiva...
13 September 2019 - Switzerland-based Roche's lung cancer drug Tecentriq (atezolizumab) has improved overall survival rate in a phase III IMpower110 study, it was reported yesterday.The trial is ...
12 September 2019 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) Janssen business has received positive results from two pivotal Phase 3 clinical studies (ASPIRE I and II) to e...
12 September 2019 - - US-based drugmaker MicuRx Pharmaceuticals, Inc has received positive top-line results for study MRX4-201, a US Phase 2 randomised, double-blind clinical trial comparing contezoli...
12 September 2019 - - US-based Fractyl Laboratories Inc. (Fractyl), a specialist in translating new insights in gut biology into transformative therapies for patients with metabolic diseases, has rece...
Related Headlines